HT
AMPE

HAP Trading’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

HAP Trading’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-50
Closed -$2K – 2744
2021
Q1 		$2K Sell
50
-13
-21% -$6.71K ﹤0.01% 1845
2020
Q4 		$3K Buy
63
+29
+85% +$9.51K ﹤0.01% 2103
2020
Q3 		$3K Buy
+34
New +$8.43K ﹤0.01% 1494

Other funds holding AMPE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
SA
Shilanski & Associates Anchorage, Alaska $376M AUM 19.08% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return

HAP Trading's AMPE Position: Q4 2013 in Review

HAP Trading sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2013, closing a stake of 598 shares — an estimated $1.35M sold.

HAP Trading first reported a position in AMPE in Q2 2013 and held it in 2 quarters. The position peaked at $1.35M in Q3 2013. 59 funds tracked by Wall St. Rank hold AMPE as of Q4 2013.

  • HAP Trading reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2013 after selling out during the quarter.
  • HAP Trading sold 598 Ampio Pharmaceuticals Inc. shares in Q4 2013, an estimated $1.35M.
  • HAP Trading first reported a position in Ampio Pharmaceuticals Inc. in Q2 2013 and held it in 2 quarters.
  • HAP Trading's Ampio Pharmaceuticals Inc. position peaked at $1.35M in Q3 2013.
  • 59 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2013.

Based on HAP Trading's 13F filing for Q4 2013, filed 10 Feb 2014.